SCHEMBL13775445

SCHEMBL13775445

COC(=O)/C=C/c1cccn1-c1ccc(Cl)cc1C(O)c1ccccc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.40
LPAR1 Q92633 3/20 0.36
NR1H4 Q96RI1 1/20 0.36
FDFT1 P37268 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
RECQL P46063 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
MAPK1 P28482 1/20 0.35
DRD2 P14416 3/20 0.35
DRD1 P21728 3/20 0.35
ADRA2A P08913 1/20 0.35
DRD4 P21917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13775240 0.93 FDFT1 (0.39) GAANR1H4FDFT1MAPTMAPK1
SCHEMBL13775457 0.93 NR1H4 (0.36) GAALPAR1NR1H4MAPK1DRD2
SCHEMBL4130145 0.91 GAA (0.40) GAALPAR1FDFT1MAPTNPC1
SCHEMBL4130138 0.91 GAA (0.40) GAALPAR1FDFT1MAPTNPC1
SCHEMBL4123855 0.90 FDFT1 (0.37) NR1H4FDFT1MAPTKDM4EALDH1A1
SCHEMBL4123861 0.90 FDFT1 (0.37) NR1H4FDFT1MAPTKDM4EALDH1A1
SCHEMBL13775454 0.87 KDM4E (0.34) NR1H4FDFT1MAPTKDM4EALDH1A1
SCHEMBL13775729 0.86 NR1H4 (0.35) GAANR1H4MAPTGPX4KDM4E
SCHEMBL4112306 0.85 FDFT1 (0.41) GAAFDFT1MAPTKDM4EALDH1A1
SCHEMBL4112300 0.85 FDFT1 (0.41) GAAFDFT1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR GAA 922/4885LPAR1 345/4885NR1H4 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.